To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of…

The National Cancer Institute awarded Astrix Technology LLC a $108,474.08 firm fixed-price Blanket Purchase Agreement (BPA) call for scientific support services, with performance in Bethesda, Maryland. The contract was awarded on February 24, 2021, with an ultimate completion date of March 6, 2022. This award represents an administrative de-obligation of unexpended and expiring fiscal year 2021 funding in preparation for the September 30, 2026 closing of the period of availability for these funds, in accordance with 31 U.S.C. Section 1552(a). The work was performed under the General Services Administration's Multiple Award Schedule (MAS) vehicle with no set-aside designations, allowing Astrix to compete on an unrestricted, open basis.

Astrix Technology LLC, a Red Bank, New Jersey-based limited liability company, is a specialized provider of scientific, research, technical, and administrative support services to federal biomedical research agencies, particularly the National Institutes of Health and its constituent institutes. The company maintains a significant $20 million single-award BPA with the NIH's Office of Logistics and Acquisition Operations through May 31, 2025, under which it has executed hundreds of task orders supporting multiple NIH institutes and centers. Under this BPA framework, Astrix provides flexible staffing solutions including grant management specialists, program managers, senior scientific researchers, clinical research nurses, laboratory technicians, and administrative personnel, enabling the National Cancer Institute and other NIH divisions to rapidly acquire specialized personnel without conducting full and open competitions for each staffing requirement.

To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of availability of these fiscal year funds.